Clinical Trials in Michigan

Showing 7001-7020 of 12,290 trials

Study of Efficacy of PEAR-004 in Schizophrenia

NCT03751280

The purpose of the study was to determine in patients currently being administered antipsychotic pharmacotherapy whether PEAR-004 could further reduce symptoms of schizophrenia as measured by the Positive and Negative Syndrome Scale (PANSS). The overall rationale for the study was to assess the first prescription digital therapeutic (PDT) in schizophrenia using a form of proven psychosocial intervention, cognitive behavioral therapy (CBT), to supplement standard of care with antipsychotic medications.

Schizophrenia

Novartis Pharmaceuticals112 participantsStarted Dec 2018

Garden Grove, California, United States • Oakland, California, United States • Torrance, California, United States +3 more locations

COMPLETEDPhase 383 miles

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

NCT04292899

The primary objective of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens with respect to clinical status assessed by a 7-point ordinal scale on Day 14.

COVID-19

Gilead Sciences4,891 participantsStarted Mar 2020

Anaheim, California, United States • Berkeley, California, United States • Burlingame, California, United States +180 more locations

Study of Efficacy of PEAR-004 in Schizophrenia

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Find Trials by Condition in Michigan

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

A Study of CLR325 in Chronic Stable Heart Failure Patients.

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Dose Range Finding Study of Bimagrumab in Sarcopenia

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

Korean Medicine for Symptomatic Lumbar Spinal Spondylolisthesis

A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies

To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.

Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies